학술논문
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)
Document Type
Article
Author
Source
In: Annals of Oncology . (Annals of Oncology, January 2020, 31(1):79-87)
Subject
Language
English
ISSN
15698041
09237534
09237534